Table 2. Longitudinal changes in clinical features in the observation group.
At diagnosis | Last visit | P value | |
---|---|---|---|
Body mass index† | 21.7 ± 2.6 | 20.6 ± 2.7 | P = 0.012* |
%VC ‡ | 88.5 ± 16.7 | 86.2 ± 17.4 | P = 0.242 |
%FEV1.0 ‡ | 91.7 ± 20.8 | 79.8 ± 20.8 | P = 0.002* |
Radiographic score (CXR) § | |||
Nodule | 5.6 ± 3.2 | 7.3 ± 5.0 | P = 0.001* |
Infiltrate | 3.0 ± 4.1 | 4.6 ± 5.9 | P < 0.001* |
Cavity | 0.1 ± 0.5 | 0.1 ± 0.4 | P = 0.569 |
Ectasis | 4.9 ± 3.0 | 6.5 ± 3.5 | P < 0.001* |
Radiographic score (CT) || | |||
Nodule | 8.4 ± 4.5 | 11.4 ± 5.4 | P = 0.005* |
Infiltrate | 2.9 ± 3.7 | 4.6 ± 4.7 | P = 0.065 |
Cavity | 0.2 ± 0.5 | 0.6 ± 1.5 | P = 0.050 |
Ectasis | 7.4 ± 4.3 | 10.6 ± 4.0 | P < 0.001* |
%VC, vital capacity as percent of predicted; %FEV1, Forced expiratory volume in 1 second as percent of forced vital capacity.
*t test (p < 0.05).
†:BMI at diagnosis are shown. n = 39, 32.
‡: Respiratory function test result are shown. n = 30, 33.
§: Radiological findings score on CXR are shown. n = 50, 50.
||: Radiological findings score on CT are shown. n = 47, 45.